Posted in | News | Nanomedicine | Nanomaterials

Applied Nanoscience to Assist EFP in Response to FDA Comments

From Applied Nanoscience Inc.Sep 20 2008

Applied Nanoscience Inc., a nanotechnology-based filtration development company, today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP), the developer of the NanoMask™, in the response to comments issued by the U.S. Food and Drug Administration (FDA) in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.

"We have been working diligently to help EFP prepare the response to FDA comments regarding the NanoMask pre-market notification, especially as it relates to the antimicrobial silver nanoparticle formulation which powers the NanoMask," said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management and scientific team plan to rapidly provide EFP with the necessary data to satisfy the FDA comments."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Applied Nanoscience Inc.. (2019, March 19). Applied Nanoscience to Assist EFP in Response to FDA Comments. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=7732.
MLA
Applied Nanoscience Inc.. "Applied Nanoscience to Assist EFP in Response to FDA Comments". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=7732>.
Chicago
Applied Nanoscience Inc.. "Applied Nanoscience to Assist EFP in Response to FDA Comments". AZoNano. https://www.azonano.com/news.aspx?newsID=7732. (accessed April 16, 2024).
Harvard
Applied Nanoscience Inc.. 2019. Applied Nanoscience to Assist EFP in Response to FDA Comments. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=7732.